Presence of common infection—cytomegalovirus—helps to explain increased other virus susceptibility in aging adults

September 6, 2012 by Jean Spinelli
Two T cells (red) interacting with a dendritic cell, another type of immune cell. T cells are immune cells important for the defense against viruses. Ongoing exposure to CMV impairs their function. Credit: HZI/M. Rohde

(Medical Xpress)—The first experimental proof that long-term infection with cytomegalovirus, or CMV, may impair the aging immune system's response to unrelated viruses – such as West Nile or the flu – has been published in the journal PLoS Pathogens.

Most adults are infected with CMV, a member of the herpesvirus family, but the virus often causes few or no symptoms. Once infected, people harbor CMV for life but a healthy immune system keeps it at bay. However, in clinical studies, CMV has been associated with poor immune function in older adults, coinciding with poor responses to other viruses, to vaccines, or poor life expectancy.

"The , present in the majority of healthy older adults, indeed erodes the against new infections," said senior investigator Dr. Janko Nikolich-Zugich, chairman of the department of immunobiology, co-director of the Arizona Center on Aging and Elizabeth Bowman Professor in Medical Research at The University of Arizona College of Medicine-Tucson. Nikolich-Zugich also is a member of the UA BIO5 Institute.

Nikolich-Zugich started this work at the Oregon Health and Science University, Portland, Ore., with his team that was led by then-postdoctoral fellow assistant Dr. Luka Čiin-Šain, who now is assistant professor and head of the Immune Aging and junior research group at the Helmholtz Centre for Infection Research in Braunschweig, Germany. Both scientists continued to study the long-term consequences of the ongoing presence of CMV in Tucson and Braunschweig, respectively.

Jennifer Uhrlaub, research associate with the UA department of immunobiology and the Arizona Center on Aging, also participated in the study.

They discovered that while over time more and more cells of the immune system – particularly the T cells, a type of white blood cell critical in the immune system's response to infection – concentrate on CMV, the in charge of responding to other viruses were fewer in numbers and functionally impaired. Similar conclusions were reached by another group from Germany, led by Dr. Urs Karrer, and are published in the same issue of PloS Pathogens.

"The ongoing presence of CMV contributes to the defects of the aged immune system, helping to explain why often are more prone to infectious diseases than young people," said Nikolich-Zugich. "Future studies will allow us to understand the effect of persisting CMV infections on immune responses, which particularly is important for the efficiency of vaccination strategies."

Explore further: Researchers show long-term consequences of chronic virus infection

More information: Mekker A, Tchang VS, Haeberli L, Oxenius A, Trkola A, et al. (2012) Immune Senescence: Relative Contributions of Age and Cytomegalovirus Infection. PLoS Pathog 8(8): e1002850. doi:10.1371/journal.ppat.1002850

Related Stories

Researchers show long-term consequences of chronic virus infection

August 16, 2012
The cytomegalovirus (CMV) is a member of the herpesvirus family. Although most people carry CMV for life, it hardly ever makes them sick. Researchers from the Helmholtz Centre for Infection Research and from the USA have ...

How a virus might make you diabetic later in life

August 27, 2012
Cytomegalovirus (CMV) is one of the viruses that most infected people carry without ill effects. Once infected you are infected for life and, although it normally is dormant, it can become active again at any point in time. ...

Surviving T cells may boost immunity in aging

August 3, 2011
UA College of Medicine research on aging and immunity has been published in the Proceedings of the National Academy of Sciences.

Recommended for you

Immunotherapy drug nearly eliminates severe acute graft-versus-host disease

December 9, 2017
Results from a phase 2 clinical trial, presented by Seattle Children's Research Institute at the 59th American Society of Hematology (ASH) Annual Meeting, show that the drug Abatacept (Orencia) nearly eliminated life-threatening ...

Location, location, location: Immunization delivery site matters

December 1, 2017
In vaccination, a certain subpopulation of dendritic cells is vital to triggering the body's adaptive immune system, report researchers at The Jackson Laboratory (JAX), Yale University and Astra-Zeneca.

An anti-aging protein could be targeted to rejuvenate immune cells

November 30, 2017
Anti-aging proteins have long been shown to protect against age-related diseases, such as cancer, neurodegeneration, and cardiovascular disease. A study by researchers at the Gladstone Institutes now reveals that one such ...

Scientists find key to miscarriages in blood clotting disorder

November 28, 2017
Monash University researchers have potentially shed light on why women with the rare autoimmune disorder Antiphospholipid syndrome (APS) are prone to successive pregnancy losses.

How do cells release IL-1? After three decades, now we know

November 28, 2017
Researchers at Boston Children's Hospital have identified, for the first time, the molecule that enables immune cells to release interleukin-1 (IL-1), a key part of our innate immune response to infections. Findings were ...

Why do more women have asthma than men? Blame hormones

November 28, 2017
Women are twice as likely as men to have asthma, and this gender difference may be caused by the effects of sex hormones on lung cells. Researchers at Vanderbilt University and Johns Hopkins found that testosterone hindered ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.